Automating structural biology experiments at LCLS
Structural Dynamics at LCLS
This study is all about making it easier and quicker to understand the tiny structures of proteins and other molecules by using advanced technology at a special research facility, which will help scientists learn more about how these molecules work in real-time.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11057649 on NIH RePORTER |
What this research studies
This research focuses on improving the automation of structural biology experiments at the Linac Coherent Light Source (LCLS) by using advanced injector-based sample delivery systems. It aims to streamline the process of solving new biomolecular structures and studying dynamic biochemical reactions through the use of photo-excitation techniques. By implementing new controls, feedback sensors, and sophisticated algorithms, the project seeks to enhance data collection and analysis, allowing for real-time monitoring and adjustments during experiments. This could lead to faster and more accurate determination of biomolecular structures.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be better understood through improved structural biology, such as cancer or genetic disorders.
Not a fit: Patients with conditions unrelated to biochemical reactions or structural biology may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly accelerate the understanding of biomolecular dynamics and improve the accuracy of structural biology, benefiting patients through advancements in drug development and disease understanding.
How similar studies have performed: Other research in structural biology automation has shown success, indicating that this approach has the potential for significant advancements.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Boutet, Sebastien — Stanford University
- Study coordinator: Boutet, Sebastien
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.